Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD

Background Patients with moderate exacerbations of COPD and the eosinophilic phenotype have better outcomes with prednisolone. Whether this outcome is similar in patients hospitalized with a severe exacerbation of COPD is unclear. We investigated the rate of recovery of eosinophilic and noneosinophi...

Full description

Bibliographic Details
Main Authors:	Bafadhel, M, Greening, NJ, Harvey-Dunstan, TC, Williams, JE, Morgan, MD, Brightling, CE, Hussain, SF, Pavord, ID, Singh, SJ, Steiner, MC
Format:	Journal article
Language:	English
Published:	Elsevier 2016

Similar Items

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
by: Siva R, et al.
Published: (2014-02-01)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
by: Bafadhel M, et al.
Published: (2015-06-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Exacerbations of COPD
by: Pavord ID, et al.
Published: (2016-02-01)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
by: Djamin, R, et al.
Published: (2019)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
by: Russell REK, et al.
Published: (2019-05-01)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
by: Bafadhel, M, et al.
Published: (2018)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)

Lung microbiome dynamics in COPD exacerbations
by: Wang, Z, et al.
Published: (2016)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
by: James Camp, et al.
Published: (2018-09-01)

Aspergillus fumigatus during stable state and exacerbations of COPD.
by: Bafadhel, M, et al.
Published: (2014)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
by: Kerkhof, M, et al.
Published: (2017)

COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
by: Hamish McAuley, et al.
Published: (2021-01-01)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
by: Barker, B, et al.
Published: (2015)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
by: Russell, R, et al.
Published: (2016)

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
by: Howell, I, et al.
Published: (2024)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
by: Huib A M Kerstjens, et al.
Published: (2021-01-01)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
by: Claus F. Vogelmeier, et al.
Published: (2019-08-01)

COPD exacerbations: transforming outcomes through research
by: Hurst, JR, et al.
Published: (2018)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
by: Bafadhel, M, et al.
Published: (2012)

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
by: Green, R, et al.
Published: (2002)

Eosinophils in asthma and airway hyperresponsiveness.
by: Brightling, C, et al.
Published: (2004)

Building toolkits for COPD exacerbations: lessons from the past and present
by: Sapey, E, et al.
Published: (2019)

Is it time to give up on "self-management" of COPD exacerbations?
by: Ramakrishnan, S, et al.
Published: (2020)